The COVID-19 vaccines made by Sinopharm and Sinovac in China, which were previously reported to be discussed at the end of April, came with a statement from the relevant World Health Organization.
In the statement made by World Health Organization vaccine regulation director Rogerio Gaspar, it was stated that the meeting on Sinopharm and Sinovac Covid-19 vaccines will take place on April 26 and at least one decision will be made regarding vaccines after the meeting.
In the statement underlined that the Chinese vaccines are in the final stage of the examination for the emergency use list by the World Health Organization (WHO), it was stated that a second meeting could be held in the week of May 3.
The World Health Organization (WHO) announced that Chinese vaccine manufacturers Sinovac and Sinopharm provided them with the necessary data on Covid-19 vaccines.
‘SAFE AND EFFECTIVE’
While it was stated that the vaccines were in accordance with the rules required by the World Health Organization, it was reported that the clinical trial data showed the vaccines ‘safe and effective’.
Stating that they need more data on vaccines, Alejandro Cravioto, the director of the Strategic Experts Group (SAGE), who made a statement on the subject, said that the interim data from vaccines developed by Chinese companies were effective as a result of the first evaluations, which is to spread corona virus vaccines in every region of the world. He said it was promising.